Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Arena Pharmaceuticals, Inc.    ARNA

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets 
Most relevant news about ARENA PHARMACEUTICALS, INC
03/20 ARENA PHARMACEUTICALS : Appoints Dr. Preston Klassen, M.D., M.H.S. as Executive ..
03/15 ARENA PHARMACEUTICALS : ARNA) Jumps on Q4 Earnings
03/14 ARENA PHARMACEUTICALS : beats 4Q profit forecasts
03/14 ARENA PHARMACEUTICALS : Provides Corporate Update and Reports Fourth Quarter and..
03/08 ARENA PHARMACEUTICALS : to Present at the 27th Annual Oppenheimer Healthcare Con..
03/06 Arena Pharmaceuticals to Provide Corporate Update and Release Fourth Quarter ..
02/14 ARENA PHARMACEUTICALS : Appoints Three New Members to Board of Directors
02/09 ARENA PHARMACEUTICALS : Announces Three Upcoming Presentations at the 12th Congr..
01/17 ARENA PHARMACEUTICALS : Technical Reports on Biotech Stocks -- ContraVir Pharma,..
01/13 ACTIVE BIOTECH STOCK NEWS : Peregrine Pharmaceuticals (PPHM), Arena Pharmaceutic..
01/05 ARENA PHARMACEUTICALS : sells underperforming weight loss drug Belviq to focus o..
01/04 ARENA PHARMACEUTICALS : Belviq story
01/04 ARENA PHARMACEUTICALS : and Eisai Amend Marketing and Supply Agreement for BELVI..
2016 ARENA PHARMACEUTICALS : Will Obesity Drug Stocks Become Mainstream Again?
2016 ARENA PHARMACEUTICALS : Eisai and Arena Pharmaceuticals Announce Regulatory Appr..
More most relevant news
All news about ARENA PHARMACEUTICALS, INC
03/20 ARENA PHARMACEUTICALS : Appoints Dr. Preston Klassen, M.D., M.H.S. as Executive ..
03/16 ARENA PHARMACEUTICALS : to Present at the 27th Annual Oppenheimer Healthcare Con..
03/15 ARENA PHARMACEUTICALS : ARNA) Jumps on Q4 Earnings
03/15 ARENA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condit..
03/14 ARENA PHARMACEUTICALS : beats 4Q profit forecasts
03/14 ARENA PHARMACEUTICALS INC : Results of Operations and Financial Condition, Finan..
03/14 ARENA PHARMACEUTICALS : Provides Corporate Update and Reports Fourth Quarter and..
03/08 ARENA PHARMACEUTICALS : to Present at the 27th Annual Oppenheimer Healthcare Con..
03/08 ARENA PHARMACEUTICALS, INC. : Biotech's Fall as President Trump to Address Prici..
03/06 Arena Pharmaceuticals to Provide Corporate Update and Release Fourth Quarter ..
More news
Sector news : Biotechnology & Medical Research - NEC
03/18DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 3rd Update
03/17DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 2nd Update
03/17DJAMGEN : Money-Back Guarantee
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- Update
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke
03/14 AstraZeneca ovarian cancer drug slows disease markedly in study
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
03/22 Arena Pharmaceuticals (ARNA) Presents At Oppenheimer 27th Annual Healthcare C..
03/22 Arena Pharmaceuticals' (ARNA) CEO Amit Munshi Presents at 27th Annual Oppenhe..
03/15 HEALTHCARE- TOP 5 GAINERS / LOSERS A : 15 pm
03/15 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
03/14 Arena Pharmaceuticals' (ARNA) CEO Amit Munshi on Q4 2016 Results - Earnings C..
03/14 Arena's Q4 beat gooses shares, up 23% after hours
Latest Tweets
03:41pUp and Down the Ladder: Job Changes.. the latest comings & goings.. recog.. 
03/22Arena Pharmaceuticals (ARNA) Presents At Oppenheimer 27th Annual Healthcare C.. 
03/17How To Profit From These Stocks: $TD $ARNA  
03/17Arena Pharmaceuticals's outperform rating reiterated at FBR & Co. $6.00 P.. 
03/15Healthcare- Top 5 Gainers / Losers as of 12:15 PM
1
More tweets
Qtime:30
Advertisement
Financials ($)
Sales 2017 37,7 M
EBIT 2017 -65,3 M
Net income 2017 -71,3 M
Finance 2017 31,0 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 8,63x
EV / Sales 2018 11,8x
Capitalization 356 M
More Financials
Chart ARENA PHARMACEUTICALS, INC
Duration : Period :
Arena Pharmaceuticals, Inc Technical Analysis Chart | ARNA | US0400471027 | 4-Traders
Full-screen chart
Technical analysis trends ARENA PHARMACEUTI...
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 4,50 $
Spread / Average Target 210%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Amit D. Munshi President, Chief Executive Officer & Director
Tina Susan Nova Chairman
Craig M. Audet SVP-Operations & Head-Global Regulatory Affairs
Kevin R. Lind Chief Financial Officer & Executive Vice President
John Adams Head-Scientific Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ARENA PHARMACEUTICALS,..2.11%356
INCYTE CORPORATION38.60%28 325
QUINTILES IMS HOLDINGS..1.87%18 277
LONZA GROUP AG2.72%10 645
CELLTRION, INC.--.--%9 610
SEATTLE GENETICS, INC.19.80%9 008
More Results